{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T07:27:41Z","timestamp":1785742061233,"version":"3.56.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.canrad.2021.11.024","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T16:08:52Z","timestamp":1645459732000},"page":"585-593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy of Kanglaite against radiotherapy-induced mucositis in head and neck cancer, a phase II trial"],"prefix":"10.1016","volume":"26","author":[{"given":"Z.-P.","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.-Y.","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.-L.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.-H.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.-X.","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.-X.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2021.11.024_bib0005","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.canrad.2021.11.024_bib0010","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.ijrobp.2007.01.053","article-title":"Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies","volume":"68","author":"Elting","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.11.024_bib0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.radonc.2016.04.001","article-title":"Management of chemo\/radiation-induced oral mucositis in patients with head and neck cancer: a review of the current literature","volume":"120","author":"Moslemi","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.11.024_bib0020","first-page":"461","article-title":"The effect of a Coix seed oil injection on cancer pain relief","volume":"27","author":"Zhang","year":"2019","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.canrad.2021.11.024_bib0025","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.7150\/jca.15407","article-title":"A randomized, open-label, safety and exploratory efficacy study of Kanglaite injection (KLTi) plus gemcitabine versus gemcitabine in patients with advanced pancreatic cancer","volume":"8","author":"Schwartzberg","year":"2017","journal-title":"J Cancer"},{"key":"10.1016\/j.canrad.2021.11.024_bib0030","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.7314\/APJCP.2012.13.10.5319","article-title":"Clinical safety and efficacy of Kanglaite\u00ae (Coix Seed Oil) injection combined with chemotherapy in treating patients with gastric cancer","volume":"13","author":"Zhan","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.canrad.2021.11.024_bib0035","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.curtheres.2008.10.004","article-title":"Kanglaite injection plus chemotherapy versus chemotherapy alone for non-small cell lung cancer patients: A systematic review and meta-analysis","volume":"69","author":"Liu","year":"2008","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.canrad.2021.11.024_bib0040","first-page":"635","article-title":"[Influence of KLT on radiotherapy effect of patients with advanced nasopharyngeal carcinoma]","volume":"10","author":"Wang","year":"2003","journal-title":"China J Cancer Prev Treat"},{"key":"10.1016\/j.canrad.2021.11.024_bib0045","first-page":"319","article-title":"The therapeutic effects of the combined therapy with Kanglaite injection and radiotherapy on nasopharyngeal carcinoma among aged cases","volume":"13","author":"Ren","year":"2005","journal-title":"Chin J Otolaryngol Integrat Trad West Medi"},{"key":"10.1016\/j.canrad.2021.11.024_bib0050","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.oraloncology.2019.09.012","article-title":"Clinical outcome and toxicity after simultaneous integrated boost IMRT in head and neck squamous cell cancer patients","volume":"98","author":"Dragan","year":"2019","journal-title":"Oral Oncol"},{"key":"10.1016\/j.canrad.2021.11.024_bib0055","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.critrevonc.2019.04.022","article-title":"Intensity modulated radiation therapy and oral mucosa sparing in Head and neck cancer patients: A systematic review on behalf of Italian Association of Radiation Oncology - Head and neck working group","volume":"139","author":"De Sanctis","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.canrad.2021.11.024_bib0060","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.radonc.2015.07.041","article-title":"CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines","volume":"117","author":"Brouwer","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.11.024_bib0065","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fonc.2017.00089","article-title":"Radiation-induced oral mucositis","volume":"7","author":"Maria","year":"2017","journal-title":"Front Oncol"},{"key":"10.1016\/j.canrad.2021.11.024_bib0070","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ijrobp.2015.07.2263","article-title":"Evaluation of the risk of grade 3 oral and pharyngeal dysphagia using atlas-based method and multivariate analyses of individual patient dose distributions","volume":"93","author":"Otter","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.11.024_bib0075","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/01635581.2013.741749","article-title":"More than 10% weight loss in head and neck cancer patients during radiotherapy is independently associated with deterioration in quality of life","volume":"65","author":"Langius","year":"2013","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.canrad.2021.11.024_bib0080","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.amjoto.2008.06.010","article-title":"Percutaneous feeding tubes in patients with head and neck cancer: rethinking prophylactic placement for patients undergoing chemoradiation","volume":"30","author":"Lawson","year":"2009","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.canrad.2021.11.024_bib0085","doi-asserted-by":"crossref","first-page":"104590","DOI":"10.1016\/j.oraloncology.2020.104590","article-title":"Factors associated with the quality of life for hospitalized patients with HPV-associated oropharyngeal squamous cell carcinoma","volume":"103","author":"Yin","year":"2020","journal-title":"Oral Oncol"},{"key":"10.1016\/j.canrad.2021.11.024_bib0090","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.bjorl.2015.12.012","article-title":"Quality of life impairment in patients with head and neck cancer and their caregivers: a comparative study","volume":"82","author":"Rigoni","year":"2016","journal-title":"Braz J Otorhinolaryngol"},{"key":"10.1016\/j.canrad.2021.11.024_bib0095","first-page":"131","article-title":"[Experimental study of the counteractive effect of Kanglaite on cancer cachexia]","volume":"25","author":"Li","year":"1998","journal-title":"Chin J Clin Oncol"},{"key":"10.1016\/j.canrad.2021.11.024_bib0100","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.12659\/MSM.909719","article-title":"Effects of Kanglaite injection on serum miRNA-21 in patients with advanced lung cancer","volume":"24","author":"Wu","year":"2018","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.canrad.2021.11.024_bib0105","doi-asserted-by":"crossref","first-page":"e16656","DOI":"10.1097\/MD.0000000000016656","article-title":"Efficacy and safety of Kanglaite injection combined with radiochemotherapy in the treatment of advanced pancreatic cancer: A PRISMA-compliant meta-analysis","volume":"98","author":"Liu","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.canrad.2021.11.024_bib0110","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.radonc.2016.06.015","article-title":"A randomised controlled trial of Caphosol mouthwash in management of radiation-induced mucositis in head and neck cancer","volume":"122","author":"Wong","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.11.024_bib0115","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.ijrobp.2016.08.047","article-title":"Salivary cytokine levels and oral mucositis in head and neck cancer patients treated with chemotherapy and radiation therapy","volume":"96","author":"Bossi","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.11.024_bib0120","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12906-019-2684-4","article-title":"Coix seed oil ameliorates cancer cachexia by counteracting muscle loss and fat lipolysis","volume":"19","author":"Liu","year":"2019","journal-title":"BMC Complement Altern Med"},{"key":"10.1016\/j.canrad.2021.11.024_bib0125","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.18632\/oncotarget.23645","article-title":"Kanglaite inhibits EMT caused by TNF-\u03b1 via NF-\u03baB inhibition in colorectal cancer cells","volume":"9","author":"Shi","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.canrad.2021.11.024_bib0130","doi-asserted-by":"crossref","first-page":"113388","DOI":"10.1016\/j.jep.2020.113388","article-title":"Kanglaite enhances the efficacy of cisplatin in suppression of hepatocellular carcinoma via inhibiting CKLF1 mediated NF-\u03baB pathway and regulating transporter mediated drug efflux","volume":"264","author":"Chen","year":"2021","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.canrad.2021.11.024_bib0135","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/lary.22434","article-title":"Protecting the oral mucosa in patients with oral tongue squamous cell carcinoma treated postoperatively with intensity-modulated radiotherapy: a randomized study","volume":"122","author":"Wang","year":"2012","journal-title":"Laryngoscope"},{"key":"10.1016\/j.canrad.2021.11.024_bib0140","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3109\/0284186X.2014.933874","article-title":"Dose-volume response in acute dysphagia toxicity: validating QUANTEC recommendations into clinical practice for head and neck radiotherapy","volume":"53","author":"Anderson","year":"2014","journal-title":"Acta Oncol"},{"key":"10.1016\/j.canrad.2021.11.024_bib0145","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.oraloncology.2017.06.026","article-title":"Impact of dose volume parameters and clinical factors on acute radiation oral mucositis for locally advanced nasopharyngeal carcinoma patients treated with concurrent intensity-modulated radiation therapy and chemoradiotherapy","volume":"72","author":"Li","year":"2017","journal-title":"Oral Oncol"},{"key":"10.1016\/j.canrad.2021.11.024_bib0150","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1016\/j.clon.2016.08.009","article-title":"Does dose to an oral mucosa organ at risk predict the duration of grade 3 mucositis after intensity-modulated radiotherapy for oropharyngeal cancer","volume":"28","author":"Yahya","year":"2016","journal-title":"Clin Oncol (R Coll Radiol)"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321822000269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321822000269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:35:42Z","timestamp":1761136542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321822000269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1278321822000269"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2021.11.024","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Kanglaite against radiotherapy-induced mucositis in head and neck cancer, a phase II trial","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2021.11.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}